<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03575286</url>
  </required_header>
  <id_info>
    <org_study_id>1</org_study_id>
    <nct_id>NCT03575286</nct_id>
  </id_info>
  <brief_title>Feasibility Study of an Automated Point-of-Care Urine Diagnostic Device for Pregnancy</brief_title>
  <official_title>Feasibility Study of an Automated Point-of-Care Urine Diagnostic Device for Pregnancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Voyant Diagnostics, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Voyant Diagnostics, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this observational study is to demonstrate the feasibility of an
      automated point-of-care urine diagnostic device in determining the pregnancy status of
      patients through urine samples collected from patients at Northwestern University. Our
      hypothesis is that this automated point-of-care urine diagnostic device will be able to
      accurately determine a patient's pregnancy status at least 95% of the time.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">June 28, 2018</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy in determining pregnancy status</measure>
    <time_frame>Time of collection - 1 month post collection</time_frame>
    <description>Compare qualitative pregnancy test results generated by Voyant's device with urine pregnancy test result(s) and, if applicable, serum pregnancy test results performed at Northwestern University. From this comparison, we will determine the accuracy of Voyant's device. We will be using the same urine sample used at Northwestern.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">123</enrollment>
  <condition>Pregnancy Related</condition>
  <arm_group>
    <arm_group_label>Pregnant female</arm_group_label>
    <description>Patient has been determined pregnant with a urine pregnancy test and, if applicable, a serum pregnancy test performed at Northwestern University.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-pregnant female</arm_group_label>
    <description>Patient has been determined not pregnant with a urine pregnancy test and, if applicable, a serum pregnancy test performed at Northwestern University.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Pregnancy test</intervention_name>
    <description>Detects hormone (hCG, Human Chorionic Gonadotropin) produced by the body during pregnancy</description>
    <arm_group_label>Non-pregnant female</arm_group_label>
    <arm_group_label>Pregnant female</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Female patients of childbearing age
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient age 18 years and older, upper age limit of 45 years

          -  Female patient

          -  Patients undergoing any procedures for pregnancy diagnosis and confirmation

          -  English speaking

        The following special population will be included:

          -  Pregnant women

        Exclusion Criteria:

          -  Adults unable to consent

          -  Individuals who are not yet adults (infants, children, and teenagers)

          -  Prisoners
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MaryEllen Pavone, MD, MSCI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University, Department of Obstetrics and Gynecology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michael Tu, MS, BS</last_name>
    <phone>214-415-4288</phone>
    <email>michael.tu@voyant.health</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claire Y Zhou, BA</last_name>
    <phone>949-355-3695</phone>
    <email>claire.zhou@voyant.health</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MaryEllen Pavone, MD, MSCI</last_name>
      <phone>312-926-8244</phone>
      <email>MaryEllen.Pavone@nm.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>June 21, 2018</study_first_submitted>
  <study_first_submitted_qc>June 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2018</study_first_posted>
  <last_update_submitted>July 7, 2018</last_update_submitted>
  <last_update_submitted_qc>July 7, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>Urine Testing</keyword>
  <keyword>Medical Diagnostics</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

